Rock J A, Dubin N H, Ghodgaonkar R B, Bergquist C A, Erozan Y S, Kimball A W
Fertil Steril. 1982 Jun;37(6):747-50. doi: 10.1016/s0015-0282(16)46332-6.
Cul-de-sac fluid from women with histologically confirmed endometriosis (n = 45) or with no evidence of endometriosis (n = 17) was removed during the proliferative phase of the menstrual cycle (days 8 to 12) and analyzed for prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), 15-keto-13,14-dihydroprostaglandin F2 alpha (PGFM), and thromboxane B2 (TXB2). The fluid volume was recorded. Peripheral blood was also obtained to determine the concentration of PGFM. Prostanoid concentrations (PGE2, PGF2 alpha, PGFM, TXB2) in women with endometriosis were not significantly different from a comparable group of disease-free women. Furthermore, a meaningful elevation of prostanoid with increasing severity of disease could not be demonstrated. Plasma PGFM was not significantly different from controls. There was, however, an elevation of PGFM with severity of disease, although this increase was not statistically significant (P = 0.11). An increase in fluid volume was not demonstrated in women with endometriosis, as compared with controls.
在月经周期的增殖期(第8至12天),采集组织学确诊为子宫内膜异位症的女性(n = 45)或无子宫内膜异位症证据的女性(n = 17)的直肠子宫陷凹液,分析其中的前列腺素E2(PGE2)、前列腺素F2α(PGF2α)、15 - 酮 - 13,14 - 二氢前列腺素F2α(PGFM)和血栓素B2(TXB2)。记录液体量。同时采集外周血以测定PGFM浓度。子宫内膜异位症患者的前列腺素浓度(PGE2、PGF2α、PGFM、TXB2)与一组无病对照女性无显著差异。此外,未发现前列腺素随疾病严重程度增加而有意义地升高。血浆PGFM与对照组无显著差异。然而,PGFM随疾病严重程度升高,尽管这种升高无统计学意义(P = 0.11)。与对照组相比,未发现子宫内膜异位症女性的液体量增加。